Literature DB >> 14764523

Clonotypic IgM V/D/J sequence analysis in Waldenstrom macroglobulinemia suggests an unusual B-cell origin and an expansion of polyclonal B cells in peripheral blood.

Jitra Kriangkum1, Brian J Taylor, Steven P Treon, Michael J Mant, Andrew R Belch, Linda M Pilarski.   

Abstract

Analysis of clonotypic immunoglobulin M (IgM) from 15 patients with Waldenstrom macroglobulinemia (WM) showed a strong preferential use of the VH3/JH4 gene families. Identification of the WM IgM V/D/J was validated using single-cell analysis, confirming its presence in most B cells. Despite the extensive hypermutated VH genes in 13 of 15 patients, statistical analysis of framework/complementary-determining region (FR/CDR) mutation patterns suggests that they might have escaped antigenic selection. Neither intraclonal diversity nor isotype switching was detectable. Membranous and secreted forms of clonotypic IgM transcripts were present in bone marrow and blood. Single-cell analysis showed that clonotypic B cells coexpress CD20, surface IgM (sIgM), and sIgD but that they lack CD138. Most B cells lacked memory marker CD27 despite their hypermutated variable regions otherwise suggestive of memory status. At diagnosis, circulating B cells in WM are largely clonotypic. However, when monoclonal IgM levels are decreased, clonotypic frequencies are substantially reduced despite elevated CD20+ cells, shown to be polyclonal by DNA sequencing and CDR3 fragment analysis. Thus, WM includes the expansion of circulating, polyclonal B cells. Overall, this work suggests that WM may originate from a largely VH3-restricted, somatically mutated, predominantly CD27(-)IgM(+)IgD+ population that cannot undergo class switching, suggestive of B cells that might have bypassed the germinal center.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14764523     DOI: 10.1182/blood-2003-11-4024

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

Review 1.  Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Casey Philipsborn; Anne Novak; Lucy Hodge; Stephen Ansell; Rafael Fonseca
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Pathophysiology of Waldenström's macroglobulinemia.

Authors:  Marvin J Stone; Virginia Pascual
Journal:  Haematologica       Date:  2010-03       Impact factor: 9.941

3.  Rituximab induces sustained reduction of pathogenic B cells in patients with peripheral nervous system autoimmunity.

Authors:  Michael A Maurer; Goran Rakocevic; Carol S Leung; Isaak Quast; Martin Lukačišin; Norbert Goebels; Christian Münz; Hedda Wardemann; Marinos Dalakas; Jan D Lünemann
Journal:  J Clin Invest       Date:  2012-03-19       Impact factor: 14.808

4.  Gene-expression profiling of Waldenstrom macroglobulinemia reveals a phenotype more similar to chronic lymphocytic leukemia than multiple myeloma.

Authors:  Wee J Chng; Roelandt F Schop; Tammy Price-Troska; Irene Ghobrial; Neil Kay; Diane F Jelinek; Morie A Gertz; Angela Dispenzieri; Martha Lacy; Robert A Kyle; Philip R Greipp; Renee C Tschumper; Rafael Fonseca; Peter Leif Bergsagel
Journal:  Blood       Date:  2006-06-27       Impact factor: 22.113

5.  Detection of MYD88 L265P in peripheral blood of patients with Waldenström's Macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Authors:  L Xu; Z R Hunter; G Yang; Y Cao; X Liu; R Manning; C Tripsas; J Chen; C J Patterson; M Kluk; S Kanan; J Castillo; N Lindeman; S P Treon
Journal:  Leukemia       Date:  2014-02-10       Impact factor: 11.528

Review 6.  Targeting the bone marrow in Waldenstrom macroglobulinemia.

Authors:  Irene M Ghobrial; Yong Zhang; Yang Liu; Hai Ngo; Feda Azab; Antonio Sacco; Abdelkareem Azab; Patricia Maiso; Brittany Morgan; Phong Quang; Ghayas C Issa; Xavier Leleu; Aldo M Roccaro
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-04-30

Review 7.  The bone marrow microenvironment in Waldenström macroglobulinemia.

Authors:  Amit Agarwal; Irene M Ghobrial
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-03-13

Review 8.  Novel treatment options for Waldenström macroglobulinemia.

Authors:  Houry Leblebjian; Amit Agarwal; Irene Ghobrial
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2013-09

Review 9.  Update on therapeutic options in Waldenström macroglobulinemia.

Authors:  Xavier Leleu; Julie Gay; Aldo M Roccaro; Anne-Sophie Moreau; Stephanie Poulain; Remy Dulery; Berenice Bro Des Champs; Daniela Robu; Irene M Ghobrial
Journal:  Eur J Haematol       Date:  2009-01       Impact factor: 2.997

10.  CD27-CD70 interactions in the pathogenesis of Waldenstrom macroglobulinemia.

Authors:  Allen W Ho; Evdoxia Hatjiharissi; Bryan T Ciccarelli; Andrew R Branagan; Zachary R Hunter; Xavier Leleu; Olivier Tournilhac; Lian Xu; Kelly O'Connor; Robert J Manning; Daniel Ditzel Santos; Mariana Chemaly; Christopher J Patterson; Jacob D Soumerai; Nikhil C Munshi; Julie A McEarchern; Che-Leung Law; Iqbal S Grewal; Steven P Treon
Journal:  Blood       Date:  2008-01-23       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.